Intrinsiqq
QuidelOrtho Corporation logo

QuidelOrtho Corporation (QDEL) Insider Trading

Last 12 months

Insiders bought $1.25M and sold $112k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan.

Net open-market
+$1.14M
8 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
6 / 1
executives and directors
Last open-market buy
Feb 2026
Feb 13, 2026

Get an email when QDEL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Feb 13
    Joseph M. Busky
    Chief Financial Officer · bought 3,370 at $23.66
    $80k
    7.0% of stake
  • Feb 13
    Brian J. Blaser
    President and CEO · bought 10,540 at $23.59
    $249k
    19% of stake
  • Feb 13
    Matthew Strobeck
    Director · bought 10,000 at $23.96
    $240k
    14% of stake
  • Dec 10, 2025
    Ann D Rhoads
    Director · bought 750 at $28.28
    $21k
    5.3% of stake
  • Nov 26, 2025
    Joseph D Wilkins Jr.
    Director · bought 370 at $27.96
    $10k
    3.2% of stake
  • Nov 25, 2025No plan
    Kenneth J Widder
    Director · sold 4,026 at $27.81
    $112k
    9.8% of stake
  • Nov 24, 2025
    Joseph M. Busky
    Chief Financial Officer · bought 4,770 at $26.06
    $124k
    14% of stake
  • Nov 21, 2025
    Mary Lake Ph D Polan
    Director · bought 1,000 at $22.43
    $22k
    3.4% of stake
  • Nov 19, 2025
    Brian J. Blaser
    President and CEO · bought 23,500 at $21.34
    $501k
    134% of stake
  • Dec 11, 2024
    Brian J. Blaser
    President and CEO · bought 6,033 at $41.42
    $250k
    New position
  • Nov 21, 2024No plan
    TC Group Cayman Investment Holdings Sub L.p.
    Large holder · sold 8,260,183 at $35.31
    $292M
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch QDEL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: In Vitro & In Vivo Diagnostic Substances

Spot a number that looks wrong? Check it in QDEL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing QDEL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.